Industry Policy Committee

Purpose: 

To promote initiatives (outside regulatory and reimbursement) which impact on industry development and sustainability and healthcare policy. 

Objectives: 

  1. Develop policy positions and engage with stakeholders on the following:  
  • Digital healthcare agenda including cybersecurity, the electronic patient record, mobile healthcare and registries.
  • Supply chain issues, including traceability of medical devices, and regularly engaged with GS1 Australia. 
  • MTP Connect initiatives, R&D, clinical trials and commercialisation. 
  • Industry input into NSW Knowledge Hun projects to support the MedTech sector. 
  • Industry input into export initiatives and issues. 
  1. Monitor the implementation of the $30 million grant for SMEs under the MTAA‐Government Agreement. 

 

MTAA Secretary: Paul Dale, Director, Policy

Member Name 

Position Title

Company 

Kate King (Co-Chair)Government Affairs and Policy Medtronic
Kirk Kikirekov (Co-Chair)Managing DirectorProspitalia h-trak
Michael ReynoldsDirector Healthcare Economics & AdvocacyBiotronik
George SidisManaging DirectorIDE Group
Geethu Roshan VergheseHealth Economics and Government Affairs ManagerBoston Scientific
Tansy MichaelBusiness ManagerFresenius Medical Care
Paul DaviesDirector, Government AffairsAbbott Medical Pty Ltd
Neroli ManningSales Director, ANZCardinal Health
Daniel KildeaSenior Government Affairs and Policy ManagerJohnson & Johnson Medical 
Kate KingGovernment Affairs and Policy Medtronic Australasia Pty Ltd 
Clinton LubckeSenior Manager, Government AffairsStryker
Rebecca CortiulaSenior Managing DirectorVarian Australasia